Search research articles
Contact Us
Filters
Showing results (51-60 of 173) with videos related to
Page
of 18
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 28, 2025
Motor and non-motor fluctuations in Parkinson's disease: the knowns and unknowns of current therapeutic approaches
Martin Regensburger, Ilona Csoti, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 23, 2021
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease
Fabian Maass, Bernhard Michalke, Desiree Willkommen, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 4, 2015
Advanced stages of PD: interventional therapies and related patient-centered care
Rejko Krüger, Rüdiger Hilker, Christian Winkler, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2023
The heterogeneity of Parkinson's disease
Ullrich Wüllner, Per Borghammer, Chi-Un Choe, et al.
Data in Brief
|
August 11, 2020
Human cerebrospinal fluid data for use as spectral library, for biomarker research
Lukas M Schilde, Simone Steinbach, Bettina Serschnitzki, et al.
Journal of Neurology
|
December 8, 2023
Reduced tear fluid production in neurological diseases: a cohort study in 708 patients
Elena Luib, Antonia F Demleitner, Isabell Cordts, et al.
Journal of Neuropathology and Experimental Neurology
|
July 9, 2014
Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease
Lars Tatenhorst, Lars Tönges, Kim-Ann Saal, et al.
Journal of Neurochemistry
|
January 5, 2024
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, et al.
Frontiers in Pharmacology
|
February 16, 2017
Rho Kinase Inhibition with Fasudil in the SOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset
René Günther, Alexander Balck, Jan C Koch, et al.
Fortschritte Der Neurologie-Psychiatrie
|
June 29, 2020
[Genetic testing for Parkinson's disease: indication and practical implementation]
Lars Tönges, Chi Wang Ip, Christian Dresel, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 173) with videos related to
Sort By:
Page
of 18
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 28, 2025
Motor and non-motor fluctuations in Parkinson's disease: the knowns and unknowns of current therapeutic approaches
Martin Regensburger, Ilona Csoti, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 23, 2021
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease
Fabian Maass, Bernhard Michalke, Desiree Willkommen, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 4, 2015
Advanced stages of PD: interventional therapies and related patient-centered care
Rejko Krüger, Rüdiger Hilker, Christian Winkler, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 11, 2023
The heterogeneity of Parkinson's disease
Ullrich Wüllner, Per Borghammer, Chi-Un Choe, et al.
Data in Brief
|
August 11, 2020
Human cerebrospinal fluid data for use as spectral library, for biomarker research
Lukas M Schilde, Simone Steinbach, Bettina Serschnitzki, et al.
Journal of Neurology
|
December 8, 2023
Reduced tear fluid production in neurological diseases: a cohort study in 708 patients
Elena Luib, Antonia F Demleitner, Isabell Cordts, et al.
Journal of Neuropathology and Experimental Neurology
|
July 9, 2014
Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease
Lars Tatenhorst, Lars Tönges, Kim-Ann Saal, et al.
Journal of Neurochemistry
|
January 5, 2024
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
Asuncion Carmona, Eleonora Carboni, Lucas Caldi Gomes, et al.
Frontiers in Pharmacology
|
February 16, 2017
Rho Kinase Inhibition with Fasudil in the SOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset
René Günther, Alexander Balck, Jan C Koch, et al.
Fortschritte Der Neurologie-Psychiatrie
|
June 29, 2020
[Genetic testing for Parkinson's disease: indication and practical implementation]
Lars Tönges, Chi Wang Ip, Christian Dresel, et al.
Page
of 18